Clinical trial
"Visiobiane Anti-age" Effects on Vision Parameters
NCT00449917 · PiLeJe, Industry · Completed
Key facts
| NCT number | NCT00449917 |
|---|---|
| Title | "Visiobiane Anti-age" Effects on Vision Parameters |
| Official title | Study of the Effects of "Visiobiane Anti-age" Dietary Supplement on Macular Pigment Optical Density, Contrast Sensibility and Visual Acuity |
| Lead sponsor | PiLeJe, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Macular Pigment Optical Density |
| Intervention type | Drug |
| Interventions | lutein, DHA, vitamins |
| Enrollment | 30 |
| Start date | Sep 1, 2006 |
| Primary completion | Jul 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Mar 21, 2007 |
| Last update posted | Oct 6, 2011 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: